In the Review Article by Rossella Talotta, Francesco Rucci, Gianfranco Canti & Francesco Scaglione, titled ‘Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: a lesson from autoimmune diseases’, which appeared in the February 2019 issue of Immunotherapy 11(3), 241–254 (2019), the authors realized that a typing error occurred in the Abstract, as well as in the sections Conclusion and Executive summary (due to the repetition of the same sentence).
The wrong sentence is: “complexes between ADAs and non-neutralising moAbs”. The sentence should have read: “complexes between non-neutralising ADAs and moAbs”.
The editors and authors of Immunotherapy would like to sincerely apologize for any confusion this may have caused our readers.